MENU
+Compare
IMMP
Stock ticker: NASDAQ
AS OF
Oct 14, 04:59 PM (EDT)
Price
$2.09
Change
+$0.10 (+5.03%)
Capitalization
276.6M

IMMP Immutep Limited Forecast, Technical & Fundamental Analysis

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease... Show more

Industry: #Biotechnology
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IMMP with price predictions
Oct 08, 2025

IMMP's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for IMMP turned positive on September 15, 2025. Looking at past instances where IMMP's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 23, 2025. You may want to consider a long position or call options on IMMP as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

IMMP moved above its 50-day moving average on September 26, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IMMP crossed bullishly above the 50-day moving average on October 01, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IMMP advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 129 cases where IMMP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IMMP moved out of overbought territory on October 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMMP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IMMP broke above its upper Bollinger Band on October 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMMP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.287) is normal, around the industry mean (23.456). P/E Ratio (0.000) is within average values for comparable stocks, (54.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.164). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (347.799).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMMP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IMMP is expected to report earnings to rise 633.50% to -14 cents per share on February 19

Immutep Limited IMMP Stock Earnings Reports
Q4'25
Est.
$-0.15
Q4'24
Beat
by $0.12
Q4'23
Missed
by $0.05
Q2'23
Est.
$-0.15
Q4'22
Beat
by $0.01
The last earnings report on February 26 showed earnings per share of -1 cents, beating the estimate of -14 cents. With 315.66K shares outstanding, the current market capitalization sits at 276.60M.
A.I. Advisor
published General Information

General Information

a developer of anti-cancer therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
264 George Street
Phone
+61 283157003
Employees
24
Web
https://www.immutep.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROYTL0.18N/A
N/A
Pacific Coast Oil Trust
LZAGY65.76N/A
N/A
Lonza Group AG
MEQYF130.66N/A
N/A
Mainstreet Equity Corp.
IMDZF133.20N/A
N/A
IMCD NV
HURRY3.00N/A
N/A
Hurriyet Gazete Tl

IMMP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMP has been loosely correlated with NCNA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMP jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
-1.00%
NCNA - IMMP
45%
Loosely correlated
+8.44%
PRRUF - IMMP
40%
Loosely correlated
N/A
BCRX - IMMP
38%
Loosely correlated
-2.49%
YECO - IMMP
37%
Loosely correlated
N/A
BYSI - IMMP
33%
Loosely correlated
-1.72%
More